Health
Mak Grants Professors David Serwadda, Phillipa Musoke a Lifetime Professor Emeritus Appointment
Professor David Serwadda has been offered a lifetime professor emeritus position at Makerere University. This decision was reached at the 489th meeting of Makerere University Council, the supreme governing body of the university, on recommendation and nomination of the chief academic organ of the University, the Senate acknowledging his exceptional contributions to academia.
The prestigious title of Emeritus Professor, is bestowed upon retired professors in line with the university’s policies, aims to retain exemplary scholars who have reached the mandatory retirement age. This is in accordance with the University’s Policy and Procedures for The Award of The Title “Emeritus Professor”; The purpose is to retain an academician who has attained his or her mandatory retirement age under the existing Employment Policy of the University.
Pursuant to university policy, an Emeritus Professor is expected to embody a set of key responsibilities, such as mentoring, continuous knowledge generation in his or her field of specialization, and promoting research and publications in peer-reviewed journals.
Professor Serwadda, 67, is an icon of academic excellence, prolific researcher and an expert in infectious disease-focused public health deeply interested in HIV clinical drug trials, HIV epidemiology, infectious disease surveillance, and HIV intervention program assessment. His great contributions have had a significant impact on the academic landscape over the course of a distinguished professional history that extend over 35 years having been appointed in Makerere University in 1993 and gone through the ranks to full Professor. This has been demonstrated in his research endeavors at Makerere University, leadership roles, and comprehensive teaching across undergraduate, master’s, and PhD levels.
In 1982, Professor Serwadda received his medical degree from Makerere University after which he went to Newcastle Upton Tyne Medical School in England for a Master of Science in Medicine in 1987. In 1990, he completed his Master of Medicine in Internal Medicine Makerere University in 1990 and subsequently obtained a Master of Public Health (Epidemiology) from the John Hopkins School of Hygiene in the United States in 1991. In recognition of his outstanding leadership in the HIV/AIDS response and his noteworthy scientific accomplishments, John Hopkins University awarded him an honorary doctorate in 2011.
In his illustrious university service career, that started off in the Department of Disease Control and Environmental Health at Makerere University School of Public Health (MakSPH), then Institute of Public Health (IPH). He was director and eventually Dean of the School of Public health for 8 years. Professor Serwadda is commended for his meritorious service to Makerere University he has excelled in teaching, mentorship of students and junior staff made significant contribution to both national and international research. Notable for his resourcefulness, extensive networks, and scholarly integrity, Prof. Serwadda’s vast contributions significantly elevated infectious disease research, boasting an impressive repertoire of approximately 400 publications.
He was instrumental in the founding of the Rakai Health Sciences Program, Makerere Walter Reed Project, and the Infectious Disease Institute (IDI) enhancing prominence both domestically and globally by means of innovative research endeavors.
Moreover, Prof. Serwadda’s remarkable memberships in eminent professional associations, broad committee participation, and recent appointment as Senior Editor of the acclaimed eLife Journal highlight his worldwide influence and dedication to the promotion of public health.
He is a reviewer of research proposals for; the National Institute of Health, Non-communicable illness in low-middle income countries 2016-; and Wellcome trust, population and public health 2008- and has attracted the University numerous research funds. Currently, he is the chair of the fundraising committee for MakSPH infrastructure, where he initiated the conversation with Johns Hopkins University and worked with the dean to negotiate a partnership that led to in the 1.1 million USD construction grant from Johns Hopkins University for American Schools and Hospitals Abroad (ASHA).
Professor Serwadda has demonstrated outstanding leadership in community service while serving in important roles at Makerere University, including Dean of the School of Public Health (2007–2009) and Director of the Institute of Public Health (2002–2007). Prior, he headed the Department of Environmental Health and Disease Control from 1999 to 2002 and served as the Executive Director of the Rakai Health Sciences Program from 1998 to 2017. He championed the creation of the MakSPH Grants Committee and Office, which he served as its chair until 2021. He currently serves on the Grants Management Committee of the Makerere University Research and Innovations Fund (MakRIF).
Several awards and honors have been bestowed upon Professor Serwadda. These include the following: The Visionary Guidance award by Uganda Health Marketing Group (2016); the Outstanding dedication to the HIV and AID response through services to TASO award in 2015; the Makerere University College of Health Sciences, School of Public Health founder; and the visionary and exceptional leadership in nurturing the HIV fellowship PROGRAM – 2014. Award of appreciation given in honor of the exceptional volume of scientific publications in 2013 Distinguished Service Award, British Council, 2008; Pioneer in Behavior-Based HIV Prevention, Harvard University, December 2006; Honorary Doctorate, John Hopkins University, May 2011; Johns Hopkins Bloomberg School of Public Health Alumni Knowledge of the World Award, October 2010.
The Vice Chancellor Professor Barnabas Nawangwe described the duo as long-serving and dedicated academics, who have diligently served Makerere University and Uganda at the College of Health Sciences until retirement.
“By accepting the appointment of Professor Emeritus, both Prof. Philippa Musoke and Prof. David Serwadda have expressed their readiness to allow Makerere University to continue tapping into their expertise and wealth of experience to mentor the next generation of academics and researchers, and to continuously generate knowledge in their fields of specialization, and promote research, publications and innovation. I thank them for their selfless service and congratulate them on this achievement,” said Professor Nawangwe.
Professor Philippa Musoke (MBChB, FAAP, PhD) is a US board-certified Paediatric Infectious Diseases specialist in the Department of Paediatrics and Child Health, School of Medicine College of Health Sciences, Makerere University and is currently based at the Makerere University-Johns Hopkins University Research Collaboration in Kampala Uganda. Prof. Musoke chairs the Ministry of Health PMTCT and the paediatric antiretroviral treatment technical subcommittees.
Prof. Musoke has dedicated the past 28 years to teaching at the Makerere Medical School, treating sick children at the Mulago National Referral Hospital, and conducting research at MU-JHU Care Ltd. She has supervised and mentored numerous medical students, postgraduate students including PhD candidates, and junior faculty. At MUJHU, she has mentored and inspired multiple junior investigators, enabling them to become independent investigators. Prof. Musoke is dedicated and committed to excellence in clinical care, training and research.
She is currently the international vice chair of the US, National Institutes of Health (NIH), Division of AIDS, IMPAACT network. Prof. Musoke has published over 150 articles in peer-reviewed journals, presented research findings at national and international conferences, and contributed to the prevention and management of HIV globally. Prof. Musoke is a technical advisor for WHO and other international health organizations.
Since 1995, she has conducted multiple perinatal HIV prevention clinical trials addressing important challenges like the benefit of single dose nevirapine (NVP) to the mother at the onset of labor and her infant at birth to reduce mother-to-child HIV transmission (MTCT) (HIVNET012), infant nevirapine dosing for prevention of breast milk HIV transmission (HPTN046), and the benefit of triple antiretroviral therapy during pregnancy and breastfeeding in further reducing MTCT (PROMISE).
Health
Ekyaalo Diagnostics; Johns Hopkins University Partners with Makerere and MUST to Advance AI Innovation for Breast Cancer Diagnosis
By Joseph Odoi
Globally, Breast cancer remains a serious health challenge, with the World Health Organization (2022) reporting over 2.3 million new cases annually and nearly 670,000 deaths. In Uganda, breast cancer is one of the leading cancers among women, yet the majority of patients are diagnosed at late stages due to delays in accessing diagnostic services, most of which are centralized at the Uganda Cancer Institute (UCI) in Kampala. Since 72% of Uganda’s population lives in rural areas, women often face late diagnosis due to long travel distances. Even after accessing care, results can take 1–6 months due to the slow process of transporting samples to central laboratories. This delay directly impacts the timely start of treatment.
To address this gap, Johns Hopkins University in collaboration with Makerere University and Mbarara University of Science and Technology (MUST), is spearheading innovative solutions that leverage artificial intelligence (AI) and low-cost technologies to improve early diagnosis and treatment.
As part of this collaboration, the Centre for Maternal, Newborn, and Child Health Research at Makerere University School of Public Health led by Associate Professor Peter Waiswa in July hosted a team of graduate biomedical engineers from the Center for Bioengineering Innovation and Design (CBID) at John Hopkins University.
The team is developing a low-cost, AI-powered technology called Ekyaalo Diagnostics, aimed at reducing the turnaround time for breast cancer diagnosis, especially in hard-to-reach areas. As part of their work, they undertook a learning tour at the Ministry of Health, Uganda Cancer Institute, and regional cancer referral centres. The purpose was to map stakeholders in the breast cancer space, gather Ekyaalo diagnostic technology usability feedback, and understand the local innovation ecosystem in breast cancer care.
Ekyaalo Diagnostics and Bringing Pathology Closer to Communities
The flagship innovation, Ekyaalo Diagnostics, is a portable AI-powered whole-slide scanner (WSS) designed to digitize cytology samples at Health Centre IVs and General Hospitals. These digitized images are securely transmitted to pathologists at higher-level facilities for timely review, eliminating the need for physically transporting samples to Kampala.
This technology has the potential to reduce diagnosis delays from several months to just a few days, thereby improving survival outcomes for breast cancer patients.
Building Local Solutions to Global Challenges
In addition to Ekyaalo Diagnostics, Makerere researchers at the Department of Biomedical Engineering are also advancing other innovations such as development of artificial breast prototypes to be used in educating women on breast cancer symptoms while Research at Mbarara University led by Dr. William Waswa, are developing PapsAI, a low-cost automated tool that support whole slide scanning of slides for cervical cancer screening.
These initiatives are aligned with the National Cancer Control Plan (NCCP) of the Ministry of Health, which emphasizes prevention, early detection, timely diagnosis.
Design Challenges and Considerations
Despite the progress being made, challenges persist, according to the team’s findings from the tour,these technologies hold great promise however their success in Uganda will depend on addressing some critical barriers.
One of the biggest challenges is limited staffing. Many lower-level health facilities lack trained laboratory personnel to prepare slides. For this reason, new technologies must be designed to be simple, user-friendly, and capable of being adopted after short training sessions.
Another major barrier is equipment maintenance. Past medical innovations in Uganda have often struggled with frequent breakdowns and software failures. The team emphasized that new diagnostic tools must be affordable, durable, and resistant to common system crashes if they are to serve rural health facilities effectively.
Finally, high operational costs continue to undermine sustainability. Some innovations fail because their maintenance costs are too high or because they are incompatible with existing health systems. Ensuring cost-effectiveness and system integration will therefore be vital for the long-term success of breast cancer diagnostic technologies in Uganda.
MORE ABOUT THE PROJECT
The project is led by the Johns Hopkins Center for Bioengineering Innovation and Design (CBID) in collaboration with Makerere’s Department of Biomedical Engineering and MUST researchers. Field learning tours have already been conducted at Mulago National Referral Hospital, Jinja, Mbarara, and Fort Portal Regional Referral Hospitals, with input from clinicians, technologists, and innovators in Uganda’s health ecosystem.
The Johns Hopkins team has conducted usability interviews with clinicians, laboratory technologists, and surgeons at multiple hospitals including Mulago, Jinja, Mbarara, and Fort Portal. They have also engaged with Uganda’s innovation ecosystem, including makerspaces and industry partners. It has been noted that the Ministry of Health together with Partners working on treatment of cancer has drafted the National Cancer Control Plan (NCCP) that is aimed at reducing incidence, morbidity and mortality through prevention and early treatment and palliative care. The Plan will give guide on health education, early detection, and diagnosis among others Special thanks go to the Center for Bioengineering Innovation and Design (CIBID) Johns Hopkins University for funding this field learning tour, Centre for Maternal Newborn and Child Health Research at School of Public health (Makerere University) for hosting the team, Departments of Bioengineering at Makerere University and Mbarara University of Science and Technology, Mulago pathology department and the Uganda cancer institute, Regional Referral hospitals of Jinja, Mbarara and Fort Portal among other General hospitals and Health center IVs visited for technical input.
Health
VectorCam Project; Makerere, Johns Hopkins, and MoH to Scale Up AI-Powered Malaria Surveillance across Uganda
On August 20, 2025, Makerere University School of Public Health (MakSPH) convened a timely workshop on Strengthening Equitable Partnerships in International Research Collaboration in Uganda. Held at the MakSPH Auditorium, the event brought together researchers, policymakers, and institutional leaders to reflect on how Uganda, and indeed the wider region, can engage more effectively and derive greater benefit from global research collaborations.
Delivering the keynote address, Prof. David Musoke Serwadda, a Professor Emeritus at Makerere University and a globally recognised HIV researcher and epidemiologist, urged a rethinking of how international research partnerships are structured. A former head of the Institute of Public Health (IPH) and later Dean of the School, serving between 2003 and 2009, Serwadda is also the founding director of the Rakai Health Sciences Programme (RHSP), which is one of Uganda’s most influential research initiatives on HIV. While acknowledging the many benefits Uganda has gained from global research collaborations, he cautioned that too many times, these partnerships remain transactional, shaped by donor priorities, bound to project cycles, and offering limited long-term value to local institutions once projects close.
Prof. Serwadda, himself a globally recognised and well-accomplished researcher, with over four decades of experience and numerous awards for his contributions to science and global health, observed that Ugandan partners are many times included in research projects for visibility rather than substance, often excluded from core roles such as Principal Investigators or from influencing agenda-setting, budget control, and authorship. “Partnerships are not an end in themselves; they exist to help us achieve mutually agreed objectives built on shared responsibility and reciprocal obligations. Too often, Southern institutions are brought into projects late, simply for optics. That is not equitable collaboration,” he insisted.
During his talk, he stressed that this imbalance undermines both research quality and sustainability, noting that normally, when local researchers are sidelined, studies often fail to align with national priorities or build capacity that endures. By contrast, partnerships that are grounded in mutual respect, fair resource sharing, co-design, and shared decision-making have the impact of producing knowledge that is globally relevant and locally impactful.
“Equity in partnerships is about fairness, ensuring that all partners, regardless of context, can contribute meaningfully. This also requires responsibility on our part in the Global South. We must insist on involvement from project conception, negotiate fair terms, and strengthen our own systems to manage collaborations effectively,” Prof. Serwadda advised, emphasising that strong institutions, clear strategy, agenda and objectives are key for local institutions to engage in mutually fair and beneficial research collaborations at the global and continental stage.
As Director and later Dean of MakSPH, Prof. David Serwadda spearheaded numerous research collaborations and attracted substantial grants that elevated the School and the University’s global standing. Today, MakSPH is recognised as Makerere University’s flagship unit for its wide-ranging partnerships and robust research management systems. Since its beginnings as a small Department of Preventive Medicine in 1954, through its transformation into the first Institute of Public Health in sub-Saharan Africa in 1975, its elevation to School status in 2007, and most recently its reinstatement as a standalone School with college status within Makerere University in January 2025, a status first granted in 2001, MakSPH has built a 70-year legacy of advancing public health through research, training, and policy engagement.
The School’s evolution, as often couched by its leadership, has been anchored on strategic and strong partnerships. These collaborations, be they local, regional or global, have driven health systems innovation, strengthened capacity, and informed policy, making partnerships the cornerstone of the School’s past achievements and future ambitions. At the celebration of the School’s 70th Anniversary, marked in December 2024, Makerere University Vice Chancellor Prof. Barnabas Nawangwe hailed MakSPH’s research output, community impact, and strong partnerships cultivated throughout the years. The Mak VC cited the School’s pioneering role in the HIV response led by Prof. Serwadda in the 1980s, the establishment of nutrition centres such as the Mwana Mugimu Unit at Mulago Hospital and across Uganda by the late Prof. John Kakitahi in the 1990s with support from Rotary International, and community projects like Kasangati Health Centre along Gayaza Road with support from the Rockefeller Foundation in the late 1950s, which advanced public education on healthy environments and wellness.
“The School of Public Health brings in almost half of all research grants at Makerere University, both in number and value, and these partnerships have been central to tackling Uganda’s public health challenges. From pioneering HIV/AIDS work that shaped global prevention strategies to interventions in maternal health, malaria, and infectious diseases, MakSPH has consistently combined academic excellence with community service. Its leadership during the COVID-19 pandemic further showed its ability to respond to national health emergencies with evidence-based solutions that directly benefit the people,” Prof. Nawangwe said with gratitude for the work done by the School through collaboration.
In 2024, the School had over 350 peer-reviewed publications in high-impact international journals as a result of this wide network and partnerships. MakSPH currently maintains a strong mix of North–South and South–South collaborations. Within the continent, the School is actively working in more than 25 countries, often partnering with multiple institutions within individual countries to advance research, capacity building, and policy influence. One such recent collaboration is the Partnership to Enhance Technical Support for Analytical Capacity and Data Use in Eastern & Southern Africa (PERSuADE) Project, funded by the Global Fund. Under PERSuADE, MakSPH, the prime grant recipient, hosted the secretariat led by Dean Prof. Rhoda Wanyenze as Principal Investigator, tasked with overall coordination across 12 countries, while a Steering Committee chaired by Prof. David Serwadda provided oversight.
PERSuADE was implemented in two phases between 2018 and 2023. The project brought together 12 universities and 12 Ministries of Health in East and Southern Africa to strengthen analytical capacity and promote data use in national health programmes, cascading skills to districts and lower facilities. In its second phase, the project trained over 1,500 health staff, including 934 at the sub-national level, in data analysis and use, and generated more than 80 analytical outputs on HIV, TB, and malaria. These informed National Strategic Plans in seven countries and improved programme strategies in all 12. Sixteen in-service staff from seven countries received specialised training in HIV key population surveillance, health information systems, and data use. The project also piloted the Maturity Index Model in five countries, helping ministries track progress in institutionalising data-driven decision-making.
In Uganda, the PERSuADE project was implemented in Kiboga, Buikwe, Kasanda, Mukono, and Mityana districts, selected by the Ministry of Health. According to the Principal Investigator, Prof. Rhoda Wanyenze, strengthening data analysis and use has greatly enhanced the capacity of Ministries of Health to deliver targeted interventions that directly benefit communities. She noted that improved analytical skills at national and subnational levels now enable ministries to identify disparities in HIV, TB, and malaria burdens, while district and facility health workers can use data to strengthen local service delivery. “With better data, districts can plan more efficiently, allocate medicines, and implement tailored prevention campaigns to address specific risks, raise awareness, and reduce new infections,” she said, emphasising the role of equitable collaboration as a key success factor in Uganda and across the continent for this partnership.
Indeed, during a learning visit to Uganda in September 2024, Dr. Estifanos Biru Shargie, Senior Specialist for Monitoring, Evaluation, and Country Analysis at the Global Fund, commended the PERSuADE Project for strengthening local capacity and fostering sustainable health system improvements through South-South partnerships among schools and ministries. “The impact has been significant. In Kiboga, I was impressed by how teams mapped gaps in services and addressed them over four years, using data to inform decisions and monitor progress. Working with Makerere University School of Public Health has been an honour. The School blends academic excellence with practical implementation, backed by strong financial management and a long-standing relationship with the Ministry of Health. Their coordination, networking, and efficiency have been exemplary,” Dr. Shargie said.
Another currently ongoing initiative at the School is the African Leadership and Management Training for Impact in Malaria Eradication (ALAMIME) program, led by MakSPH with ten participating institutions across nine malaria-endemic countries, funded by the Bill & Melinda Gates Foundation. Co-led by Prof. Elizeus Rutebemberwa and Prof. Dosithée Ngo Bebe, ALAMIME is cultivating the leadership Africa needs to defeat malaria by strengthening institutions, building capacity, and fostering regional networks. In 2024 alone, the program trained over 250 participants, nearly half women, from national malaria programs, ministries, and NGOs. Through structured training, alumni-led webinars, and cross-country exchanges, the program has demonstrated how equitable, multi-country partnerships translate investment into sustainable systems and shared momentum toward malaria elimination.
For nearly 15 years now, MakSPH has also hosted the NTU–Mak Partnership, a collaboration between Makerere University and Nottingham Trent University, first conceived in 2010, with Assoc. Prof. David Musoke and Prof. Linda Gibson as the Uganda and UK Co-Leads. One of the key reasons for the success of this partnership is equity, and it has since attracted over £1.4 million in grants, trained more than 900 Village Health Teams in Wakiso District, supported over 350 practitioners in antimicrobial stewardship, and facilitated exchanges for more than 200 students and faculty. It has also equipped community health workers to respond to non-communicable diseases, antimicrobial resistance, and the COVID-19 pandemic, while generating over 30 peer-reviewed publications and convening global platforms such as the first International Community Health Worker Symposium, held in Kampala in 2017.
Dr. Musoke, the Co-Principal Investigator for the project on strengthening equitable research collaborations in Uganda, described the NTU-Mak partnership as a model North–South partnership that has produced both joint scholarship and lasting institutional ties. He noted that its success has inspired wider collaborations, as the current project on equitable partnerships builds on this foundation. Emerging from a British Academy regional workshop in Nairobi in 2024, MakSPH extended its engagement to Mountains of the Moon University (MMU), Uganda Martyrs University (UMU), and the National Agricultural Research Organisation (NARO). Together with Nottingham Trent University, these institutions are now advancing reforms to embed equity in research partnerships across Uganda’s research ecosystem.
-
General2 weeks agoAdmission Lists -Disability and District Quota Schemes 2025/26
-
General2 weeks agoChange of Course/Programme for Undergraduate Admissions 2025/2026
-
General1 week agoFirst-Year Student’s Joining Instructions 2025/26
-
General2 weeks agoTransform Ivory Tower into Impact Tower – First-ever CEOs’ Summit
-
Innovation2 weeks agoMak-RIF Bi-Annual Bulletin Issue 4: Jan-Jun 2025